| Literature DB >> 23573412 |
Natalia Arias1, Marta Méndez, Camino Fidalgo, María Ángeles Aller, Jaime Arias, Jorge L Arias.
Abstract
Cirrhosis is a common disease in Western countries. Liver failure, hyperammonemia, and portal hypertension are the main factors that contribute to human cirrhosis that frequently leads to a neuropsychiatric disorder known as hepatic encephalopathy (HE). In this study, we examined the differential contribution of these leading factors to the oxidative metabolism of diverse brain limbic system regions frequently involved in memory process by histochemical labelling of cytochrome oxidase (COx). We have analyzed cortical structures such as the infralimbic and prelimbic cotices, subcortical structures such as hippocampus and ventral striatum, at thalamic level like the anterodorsal, anteroventral, and mediodorsal thalamus, and, finally, the hypothalamus, where the mammillary nuclei (medial and lateral) were measured. The severest alteration is found in the model that mimics intoxication by ammonia, followed by the thioacetamide-treated group and the portal hypertension group. No changes were found at the mammillary bodies for any of the experimental groups.Entities:
Year: 2013 PMID: 23573412 PMCID: PMC3612461 DOI: 10.1155/2013/390872
Source DB: PubMed Journal: Int J Hypertens Impact factor: 2.420
Figure 1Cytochrome oxidase (COx) histochemistry in the sampled regions in which the squares used to take the measures were presented. Prelimbic (PL) and infralimbic (IL) cortex, accumbens core and shell (AcC and AcS), thalamic nuclei (ADT, AVT, and MDT), dorsal hippocampus (CA1, CA3, and DG) and Mammillary nuclei (mMM, lMM, and LM). Scale bar: 1 mm.
Metabolic activity of the selected brain regions in the studied groups.
| PH | HA | TAA | |
|---|---|---|---|
|
| |||
| PL | 18.364 ± 0.460a,b | 26.781 ± 1.032 | 22.591 ± 0.379a |
| IL | 18.470 ± 0.504a | 26.988 ± 0.916 | 19.432 ± 0.401a |
|
| |||
| AcC | 21.362 ± 0.395a,b | 31.812 ± 1.032 | 25.552 ± 0.498a |
| AcS | 22.210 ± 0.748a,b | 36.940 ± 1.227 | 32.409 ± 0.715a |
|
| |||
| ADT | 30.525 ± 0.736a,b | 50.930 ± 2.024 | 40.025 ± 1.302a |
| AVT | 24.717 ± 0.525a | 31.753 ± 1.412 | 27.631 ± 1.120a |
| MDT | 19.307 ± 0.879a | 27.361 ± 0.809 | 18.242 ± 0.921a |
|
| |||
| DG | 23.413 ± 0.500a,b | 39.550 ± 1.75 | 32.663 ± 1.739a |
| CA3 | 16.318 ± 0.488a,b | 22.633 ± 0.763 | 12.592 ± 0.568a |
| CA1 | 18.128 ± 0.707a | 24.820 ± 0.915 | 18.250 ± 0.915a |
|
| |||
| mMM | 22.949 ± 1.151 | 23.490 ± 1.336 | 23.769 ± 1.479 |
| lMM | 17.643 ± 0.950 | 16.792 ± 0.633 | 15.777 ± 0.597 |
| LM | 25.923 ± 1.113 | 26.624 ± 1.246 | 26.665 ± 0.489 |
Values are mean ± SEM.
PH: portal hypertension, HA: hyperammonemia, TAA: thioacetamide.
a P < 0.05 statistically significant value in relation to HA.
b P < 0.05 statistically significant value in relation to TAA.